Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Surufatinib
Fallopian Tube Carcinosarcoma
Sun Yat-sen University
P1/2
CCC
(48)
Surufatinib
Triple-Negative Breast Carcinoma
Huihua Xiong
P1/2
CCC
(48)
Surufatinib
Osteosarcoma
Hutchmed
P1/2
CCC
(48)
Surufatinib
Ovarian Carcinoma
Sun Yat-sen University
P1/2
CCC
(48)
svg103
Isolated Focal Cortical Dysplasia
Sovargen
P1/2
CCC
(48)
SX682
Laryngeal Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
SX682
Hypopharyngeal Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
SX682
Colon Adenocarcinoma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
SX682
Rectum Adenocarcinoma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
SX682
Oral Cavity Squamous Cell Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
SX682
Oropharynx Squamous Cell Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
SX682
Paranasal Sinus Neoplasm
National Cancer Institute (NCI)
P1/2
CCC
(48)
SX682
Colon Carcinoma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
SX682
Malignant Colon Neoplasm
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Tak-500
Head And Neck Squamous Cell Carcinoma
Takeda
P1/2
CCC
(48)
Talazoparib
Hepatoblastoma
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Malignant Germ Cell Tumor
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Neuroblastoma
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Osteosarcoma
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Peripheral Primitive Neuroectodermal Tumor
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Rhabdoid Tumor
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Rhabdomyosarcoma
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Soft Tissue Sarcoma
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talazoparib
Wilms Tumor
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Talogreptide Mesaroxetan
Castration-Resistant Prostate Carcinoma
Clarity Pharmaceuticals Ltd
P1/2
CCC
(48)
Showing 1851 to 1875 of 6,308 assets
Previous
Page 75 of 253
Next